EGFR and breast cancer: The ectopic distribution of the EGFR is an unfavorable marker in various cancers including lung cancer, breast cancer, cervical cancer, and head and neck squamous cell carcinoma, which is related to radiotherapy resistance and dysregulation of the intracellular reduction/oxidation (ReDox) state [86,138,139,140].